HOME >> BIOLOGY >> NEWS
Smac-ing back at cancer cells

By mimicking a molecular switch that triggers cell death, researchers have killed cells grown in the laboratory from one of the most resilient and aggressive cancers a virulent brain cancer known as glioblastoma. The new approach to tricking the cell-death machinery could be applied to a wide range of cancers where this pathway, known as apoptosis, has been inactivated.

The researchers -- led by Xiaodong Wang, a Howard Hughes Medical Institute investigator at the University of Texas Southwestern Medical Center at Dallas and his colleagues Patrick Harran and Jef De Brabander -- published their findings in the September 3, 2004, issue of the journal Science.

Many cancer cells are particularly hardy because they have switched off the apoptotic machinery at one point or another, protecting them from the suicide process that their aberrant behavior would otherwise trigger.

To reactivate the cell-death pathway in cancer cells, the researchers sought to create a molecular mimic of a protein called Smac, which promotes apoptosis. Normally, when apoptosis is activated in cells that are damaged or no longer needed, Smac is released from the mitochondria, which are the cell's power plants. Once released, Smac binds to a group of gatekeeper proteins known as "inhibitor of apoptosis proteins" (IAPs), which normally hold in check the cell's chief executioner enzymes. These enzymes, called caspases, wreak lethal havoc in cells targeted for apoptosis. Smac's action is why it was named the "second mitochondria-derived activator of caspases."

Specifically, Wang and his colleagues sought to make a small molecule to mimic the function of the Smac protein, since a smaller molecule is better able to pass through the cell membrane to reach the cell's interior, where IAP-caspase resides.

"The idea for making this inhibitor molecule first arose in previous studies when our collaborator Dr. Yigong Shi solved the crystal structure of Smac interacting with
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
8-Sep-2004


Page: 1 2 3

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. Chemical derived from vitamin-E shows early promise as cancer drug
4. New molecular link key to cellular proteins involved in cancer progression, other diseases
5. Phase II trials of second-generation antisense cancer drug planned following successful early study
6. Trial shows which brain cancer patients benefit from temozolomide
7. Genetic differences might help distinguish thyroid cancers
8. Evidence builds for potential new cancer drug target
9. New sequence involved in DNA replication timing may aid in cancer detection
10. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
11. Cannabis may help combat cancer-causing herpes viruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: